SOPHiA GENETICS SA expected to post a loss of 19 cents a share - Earnings Preview

What happened

SOPHiA GENETICS SA reports results on November 3 for the quarter ending September 30, 2026. Analysts expect revenue of $24.035 million, up 23.5%, and a loss of 19 cents per share, based on estimates from 5 analysts using LSEG data.

Confirmed

Global impact / market context

Analysts expect revenue growth but still expect a loss, so investors will compare the actual loss with the 19-cent estimate. The company has missed earnings estimates in each of the last eight quarters shown, which may make investors cautious about the upcoming report.

Analyst inference

The average analyst rating is buy, with 5 strong buy or buy ratings and no hold or sell ratings. The median 12-month price target of $9.00 is about 12.9% above the last closing price of $7.97, suggesting analysts see room for the stock to rise.

Analyst inference

What to watch

1. Watch whether revenue reaches the expected $24.035 million, which would be a 23.5% increase from $19.46 million a year earlier. Confirmed
2. Watch whether the company reports a loss smaller than 19 cents per share, since it has missed estimates in each of the last eight quarters shown. Proposed
3. Watch whether management explains how revenue growth affects costs and cash available, which matters because the company is still expected to report a loss. Analyst inference

Evidence

• Original source link unavailable